Prostate Cancer Clinical Trial: RTIRE

For more info, visit: https://www.primrmed.com/cancer-clini...

The video discusses a new study for patients with intermediate risk prostate cancer, in which a new treatment approach combining radiation therapy and irreversible electroporation (IRE) is being evaluated. With the use of scans such as MRI and PSMA PET, doctors can now locate the most aggressive and less aggressive parts of the prostate cancer.

The study aims to determine whether adding lower dose radiation therapy to the entire prostate after IRE, known as RTIRE, increases the chance of prostate cancer never returning and preserves quality of life, while avoiding the side effects that may happen with surgery or high dose radiation therapy.